A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
NYU Langone Health · with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NCT04867395
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 282
- US sites recruiting
- 1
- Study start
- July 23, 2021
- Record last updated
- July 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The overarching objective of this study is to make it easier for parents of children with medical complexity (CMC) to take care of their children after discharge home from the hospital and reduce the chance of post-hospitalization morbidity (meaning bad outcomes such as readmissions) after discharge. CMC, or those with multiple chronic conditions, progressive conditions, or technology dependence, are at high risk for post-hospitalization morbidity.
Being studied: HELPix Care Plan
Conditions: Children With Medical Complexity (CMC)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Parents
- English or Spanish-speaking
- Parent or legal guardian and primary caregiver of child who has medical complexity (defined by significant chronic conditions in ≥2 body systems, progressive conditions associated with decreased life expectancy, dependence on technology for >6 months [e.g., respiratory equipment, central lines, feeding tubes], or progressive/metastatic malignancies) who was admitted to the acute or intensive care units
- The individual's child is ≤18 years old
- The individual's child was discharged home or is expected be discharged home on ≥1 daily medication.
- Willingness to be randomized to intervention group
- Willingness and ability to participate in study procedures
Exclusion Criteria
Parents
- Caregiver \<18 years old
- Poor visual acuity (\<20/50 corrected on Rosenbaum screener for in-person recruitment; by subject report for phone recruitment)
- Self-reported hearing difficulty
- Previously enrolled.
Recruiting US locations
NYU Langone Health
New York, NY 10016
Site contact: Andrew Glick, MD, MS · 212-263-8198 · andrew.glick@nyulangone.org
Study contacts (from the official record)
- Alexander F Glick, MD, MS · 212-263-8198 · alexander.glick@nyulangone.org
Similar studies in New York
All healthy volunteers studies in New York →- RecruitingHealthy volunteers
Using Middle School Science Teachers to Address Cancer Health Disparities
Weill Medical College of Cornell University
- Location
- New York, NY + 1 other US site
- Eligibility basics
- Ages 10+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- New York, NY + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Staten Island, NY + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- East Syracuse, NY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1